Table 2.

Number of patients developing post-CT AKI in the ICM and control groups with varying baseline eGFR. (eGFR in mL/min/1.73 m²).

Baseline eGFR	ICM group (%)	Controls (%)
>90	13 (5.91%) (n = 220)	2 (1.31%) (n = 153)
60–90	19 (9.13%) (n = 208)	2 (1.23%) (n = 162)
45–60	7 (7.37%) (n = 95)	3 (4.48%) (n = 67)
<45	23 (14.9%) (n = 154)	10 (9.52%) (n = 105)
Total	62 (9.16%) (n = 677)	17 (3.49%) (n = 487)